Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation.
about
Clinical research priorities in adult congenital heart diseaseThe Total Artificial Heart in End-Stage Congenital Heart DiseaseThe Fontan pathway: What's down the road?Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity.Cavopulmonary assist for the univentricular Fontan circulation: von Kármán viscous impeller pumpMechanisms of systemic adaptation to univentricular Fontan conversion.Three-dimensional simulations in Glenn patients: clinically based boundary conditions, hemodynamic results and sensitivity to input data.Connection of discontinuous pulmonary arteries in patients with a superior or total cavopulmonary circulation.Cavopulmonary assist: (em)powering the univentricular fontan circulation.Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of conceptA consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011.Performance evaluation of a pediatric viscous impeller pump for Fontan cavopulmonary assist.Long-Term Serial Follow-Up of Pulmonary Artery Size and Wall Shear Stress in Fontan Patients.Magnetic resonance imaging catheter stress haemodynamics post-Fontan in hypoplastic left heart syndromePeripheral vascular adaptation and orthostatic tolerance in Fontan physiology.Sildenafil in the management of the failing Fontan circulation.Review of inhaled nitric oxide in the pediatric cardiac surgery setting.Modulation of pulmonary vascular resistance as a target for therapeutic interventions in Fontan patients: focus on phosphodiesterase inhibitors.Protein-losing enteropathy and the Fontan operation.Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.Perioperative Considerations for Children With Right Ventricular Dysfunction and Failing Fontan.Pulmonary vasodilator therapy in the failing Fontan circulation: rationale and efficacy.Drug therapy in the prevention of failure of the Fontan circulation: a systematic review.Impact of oral chronic administration of sildenafil in children and young adults after the Fontan operation.Elevated Low-Shear Blood Viscosity is Associated with Decreased Pulmonary Blood Flow in Children with Univentricular Heart Defects.Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?The Pulmonary Circulation in the Single Ventricle PatientPlasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease.Non-invasive assessment of ventricular force-frequency relations in the univentricular circulation by tissue Doppler echocardiography: a novel method of assessing myocardial performance in congenital heart disease.New insights into the aspects of pulmonary diffusing capacity in Fontan patients.The effect of bosentan in patients with a failing Fontan circulation.Inhaled nitric oxide for elevated cavopulmonary pressure and hypoxemia after cavopulmonary operations.Hemodynamic impact of pulmonary vasodilators on single ventricle physiology.The respiratory system in pediatric chronic heart disease.Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation.Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease.Measurement, interpretation and use of hemodynamic parameters.Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.Role of paediatric assist device in bridge to transplant.
P2860
Q30418760-3F156792-A10E-4024-A5BC-25964273D5FDQ33650322-8AA22D95-FDA0-4F2F-BFD8-DD8A00129D60Q33735733-36E44062-FB7D-4FF2-96B2-A227816F1592Q33840076-CEB12B56-E2C8-43CE-8540-A424DA558E77Q34076997-82E08222-4787-4772-82B6-2DC4E2690207Q34077394-5DA45738-87A5-4E90-87D0-8F38C7A4EB71Q34100906-D221D215-154C-480D-8AF2-AD559F4DA984Q34488910-187E3396-36D4-426D-98FC-F30B11A4FB7AQ34777665-564DD262-0A3B-4882-9856-1C2ECBB01B7BQ34890485-D7282D22-5D63-49F5-BF64-6F3D94C7C480Q35181115-593F12D0-FC4B-436D-8D18-93D90EA149CCQ36476348-ED1EAD0E-2D97-4798-A49E-27E1C63D7A9FQ36783040-53CA15AE-0E66-428E-A55D-B8602271923AQ36912434-FAD0BBD7-A85A-40B2-97D6-D9C94D50E431Q37469336-327F938A-A6FC-41EC-AD2D-D684170CA044Q37762313-0C10EB10-9336-425F-8CA9-16814034C353Q37980691-14024EF0-7886-4CA3-AA59-0E540BA042D5Q37993150-3322C464-90E8-4F0B-974D-2BD97F504B56Q38003837-653F2070-C813-4D97-A84D-5CD1CB8EC197Q38126437-BDBD3EC6-0BF6-4162-B6BA-B1AC60C96516Q38569319-EB9B69DC-437F-4868-8253-CC06422C1CC0Q38671350-B216156B-958C-4403-B24B-5B82808BF883Q38762647-8B9C0CF4-6AF6-4F94-BEFF-A06FDE8CCA12Q39706269-C7402D9B-0B31-40A9-A9ED-9B76D150DA48Q39989220-919EBBA6-A0D0-4870-9893-6B309DE041BFQ41493475-22762DF9-71E5-4FCA-A9E0-76BF5F021831Q41552536-67C315B7-E394-4FD6-818C-160DF4799FC0Q41577676-DA08083E-235B-424B-8F2F-1E00A71DB985Q43012284-DA4C31A9-AE7C-4150-A013-10AA127F86BBQ44394559-AF0E6A83-FA96-42AB-AEE2-5312D0E940B1Q45972746-EB126320-BB14-4AE9-BF30-B4295F64BFB0Q45995680-1F375262-4E8C-497C-A6C8-BB65C4D7CB2EQ47385953-4D12A9D1-5E80-40E5-8267-FBED5F46E2F9Q47596180-84261ACA-264A-4930-987B-10B60DCAF604Q47920226-4F015427-F8CF-4BA9-AF2E-49A757E7CA6FQ48107151-9E6684D7-7466-4CE2-8E7A-8EFD4AAC0D09Q48410840-FD0B909C-310A-47CC-9210-84917AFAB174Q48432056-E1142BBC-3A84-4CCE-B718-A6B077EE37DBQ49791500-C10D916E-0DE6-4BEC-827D-763E868D6FA1Q50331554-C8D24D1D-9452-46DC-9B3C-0928FEEE991A
P2860
Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@ast
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@en
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@nl
type
label
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@ast
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@en
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@nl
prefLabel
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@ast
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@en
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@nl
P2093
P1433
P1476
Basal pulmonary vascular resis ...... e after Fontan-type operation.
@en
P2093
Deanfield JE
Khambadkone S
Redington AN
de Leval MR
P304
P356
10.1161/01.CIR.0000074210.49434.40
P407
P577
2003-06-23T00:00:00Z